Pharmaceuticals
-
HIV prevention "clinically effective"
HIV-prevention treatment is clinically effective, according to an expert analysis for the UK government. Read more
-
Warning on immunotherapy side-effects
Studies of new cancer treatments, such as immunotherapies, often fail to report adverse events adequately, a European conference was told yesterday. Read more
-
Cancer pill non-adherence studied
Cognitive disorders can affect adherence to oral cancer therapies, a European conference has heard. Read more
-
Painkillers linked to increased risk of heart failure
Commonly used prescription painkillers have been linked to an increased risk of heart failure, a new study out this week has revealed. Read more
-
HIV antibody creation tested
Swiss researchers have unveiled new findings about HIV antibodies in the hope of paving the way to vaccine development. Read more
-
Phase I trial expectations ‘unrealistic’
Cancer patients who are considering participating in phase I clinical trials have “unrealistic expectations” of the benefits, a new study out today has found. Read more
-
UN pledges to tackle drug resistance
A global agreement to tackle antimicrobial resistance has been announced. Read more
-
Innovative MS treatment on the cards
New and innovative treatments for autoimmune diseases could soon be tested after a mechanism involved in their development was identified by German researchers. Read more
-
TB cure rates increased
Europe may be having more success against multi-drug resistant TB than previously thought, according to British researchers. Read more
-
Smokers helped to quit by e-cigarettes
New figures suggest that about 18,000 people in England have moved from conventional cigarettes to e-cigarettes. Read more
